Preclinical studies indicate increased IL‐6/JAK/STAT3 signalling in tumour cells and tumour infiltrating immune cells could promote tumour proliferation, survival, invasion and metastasis, and might suppress anti‐tumour immunity.68 This evidence concerns the gene IL6 and neoplasm.